Editors Choice

There can be no escaping the mental terror, anguish, and helplessness of children in war-torn countries during the 21st century, but what does it bode for their futures?

Omicron “Mild”? Hardly.

Dr. Hesham A. Hassaballa - January 6, 2022

I keep reading that the Omicron variant is much milder: "The details of the Omicron variant are becoming clearer, and they are encouraging," writes...

Research Drives AMD Treatments Toward Targeted Therapies

Deborah Ferrington PhD - March 26, 2024

Age-related macular degeneration (AMD) is the leading cause of blindness for those 55 years and older.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

The Hidden Cost of Global Conflict: Why Health Security Is the First Casualty

DADS GET POSTPARTUM DEPRESSION TOO!

The Strait That Ships the World’s Vaccines

Of Measles and Midterms

LATEST

TRENDING

Reiner Fuellmich Fact Checked and Exposed as a Covid Conspiracy Con

Video of Jordon Walker, Supposed Pfizer Researcher, Goes Viral

We Call Out Reiner Fuellmich as a Fraud. The Covid Conspirator Investigated

Pfizer Confirms mRNA Vaccine Never Tested for Preventing COVID Transmission

Fact-Checking Geert Vanden Bossche. Cashing in on Covid Misinformation

Gabor Maté’s Bizarre Ideas on Connections Between Stress and Disease

Worshiping at The Alter of Zach Bush’s Messianic Health Cult

Exposing America’s Frontline Doctors and Their Financial Empire Built on Hydroxychloroquine

Prof Dolores Cahill is the Latest Quack to Commit Career Suicide

Who Not To Trust: A List of 10 Covid-19 Charlatans and “Medical” Snake-Oil Salesmen

EDITORS CHOICE

Patients: Up Where We Belong

War Tears Children Apart in Invisible, Prolonged Ways Into Their Futures

Omicron “Mild”? Hardly.

Research Drives AMD Treatments Toward Targeted Therapies

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories